ZOM News and Press, Zomedica Pharmaceuticals Corp. From 12/15/22

ANN ARBOR, MI / ACCESSWIRE / December 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announces an update interview with the Wall Street Analyzer, and Larry Hea...

Zomedica press release ( NYSE: ZOM ): Q3 GAAP EPS of -$0.005. Revenue of $4.78M (+23800.0% Y/Y). PulseVet unit sales to Small Animal Veterinarians totaled 13, a 225% increase over its third quarter 2021 Small Animal Veterinarian sales as a standalone company, of 4 unit...

ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company", a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three- and nine-mon...

ANN ARBOR, MI / ACCESSWIRE / October 18, 2022 / Zomedica Corp. (the "Company") (NYSE American:ZOM) announced today that Larry Heaton, Zomedica's Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the LD Micro Main Event XV Conference on Octo...

ANN ARBOR, MI / ACCESSWIRE / September 28, 2022 / Zomedica Corp. (NYSE American:ZOM) announced today that Larry Heaton, Zomedica's Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the Dawson James Securities Small Cap Growth Conference on ...

ANN ARBOR, MI / ACCESSWIRE / September 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering novel diagnostic and therapeutic products for companion animals, today announced the commercial launch of its newest assay - Free T4 (fT4...

Summary Zomedica is a developing company providing diverse veterinary supplies for large and small animals. Zomedica's PulseVet acquisition has transformed the company. As a tiny company undergoing major transformation, Zomedica's financial situation is highly speculative. ...

ANN ARBOR, MI / ACCESSWIRE / September 12, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton, Chief Executive Officer, will provide a strategic update and...

The following slide deck was published by Zomedica Corp. in conjunction with this event. For further details see: Zomedica (ZOM) Investor Presentation - Slideshow

Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health....